05/13/2024
6:30 AM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Quince Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:10 PM | Quince Therapeutics (Filer)
| Form ARS | |
04/11/2024
3:39 PM | Quince Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
4:21 PM | Quince Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/01/2024
3:50 PM | Quince Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
5:09 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
02/15/2024
5:14 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
8:00 AM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SC 13G | |
02/07/2024
9:50 AM | BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
5:02 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:50 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:53 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:00 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
3:48 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:08 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
5:21 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:30 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
12:38 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
4:54 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:42 PM | Janhofer Guenter (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:43 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2023
6:46 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:34 PM | Janhofer Guenter (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
3:05 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
4:40 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
4:43 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:18 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
5:42 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
5:08 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
5:18 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
5:21 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
5:23 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
6:16 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
10:07 AM | BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
| Form SC 13G | |
05/26/2023
4:45 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:47 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:49 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:50 PM | Quince Therapeutics (Issuer)
RYAN UNA S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:53 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
3:23 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
I’m afraid WWIII is a very real possibility (Ad) As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.”
That's also why I've produced this new film. Take a look. |
